Del Global stakes claim in European states

Article

Del Global Technologies signed a distribution agreement with the European Distribution Organization granting the EDO the right to act as the exclusive distributor of Del Global’s medical imaging systems.Countries in the EDO include Poland, the Czech

Del Global Technologies signed a distribution agreement with the European Distribution Organization granting the EDO the right to act as the exclusive distributor of Del Global’s medical imaging systems.

Countries in the EDO include Poland, the Czech Republic, the Slovak Republic, Hungary, Greece, Romania, Turkey, Bulgaria, Yugoslavia, Russia, and others in the Commonwealth of Independent States. Del Global president and CEO Leonard Trugman said he looks forward to the increased presence of his company in these countries.

Del Global obtained a 19% stake in Villa Sistemi in January, along with the nonrevocable option to increase its ownership share to 80%, and it decided to exercise that option in April (SCAN 5/10/00). This month, the FDA gave its approval for Del Global to market Villa Sistemi’s Vision tilting table for radiographic and fluoroscopic examinations.

Del Global is a Valhalla, NY-based designer, developer, and manufacturer of medical and dental imaging systems. Villa Sistemi is based in Milan, Italy (SCAN 6/21/00).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.